BIO
Bio-Rad Laboratories IncNYSEHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$7.88B
P/E Ratio
49.05
EPS
$6.00
Beta
1.08
52W High
$343.12
52W Low
$219.94
50-Day MA
$279.94
200-Day MA
$293.79
Dividend Yield
—
Profit Margin
6.52%
Forward P/E
35.97
PEG Ratio
1.19
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
Fundamentals
| Revenue (TTM) | $2.59B |
| Gross Profit (TTM) | $1.35B |
| EBITDA | $444.80M |
| Operating Margin | 5.76% |
| Return on Equity | 2.50% |
| Return on Assets | 1.79% |
| Revenue/Share (TTM) | $95.80 |
| Book Value | $255.37 |
| Price-to-Book | 1.20 |
| Price-to-Sales (TTM) | 3.04 |
| EV/Revenue | 3.189 |
| EV/EBITDA | 18.18 |
| Quarterly Earnings Growth (YoY) | -83.00% |
| Quarterly Revenue Growth (YoY) | 1.10% |
| Shares Outstanding | $21.70M |
| Float | $20.90M |
| % Insiders | 16.38% |
| % Institutions | 94.44% |
Historical Volatility
HV 10-Day
41.93%
HV 20-Day
57.67%
HV 30-Day
55.64%
HV 60-Day
45.83%
HV Rank
83.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($297.00 target)
4
HoldMore HEALTHCARE Stocks
Data last updated: 6/6/2026